首页> 外国专利> CIS-PT (II) COMPLEXES OF D1.3.5.(10)-OESTRATRIEN -3-OL-17-ONE 3-METHOXYPREGNEN -20-ONE AND 5 - ANDROSTAN- 17¯-3-ONE DERIVATIVES. THEIR PREPARATION AND BIOLOGICAL ACTIVITY

CIS-PT (II) COMPLEXES OF D1.3.5.(10)-OESTRATRIEN -3-OL-17-ONE 3-METHOXYPREGNEN -20-ONE AND 5 - ANDROSTAN- 17¯-3-ONE DERIVATIVES. THEIR PREPARATION AND BIOLOGICAL ACTIVITY

机译:D1.3.5。(10)-雌三烷基-3-OL-17-一3-甲氧基苯丙氨酸-20-一和5--雄酮-17′-3-一衍生物的CIS-PT(II)配合物。它们的制备和生物活性

摘要

The present invention refers to the compound, the isolation and the characterization of cis-dichloro-[3-hydroxy-D1.3.5(10)-estratrieno-17b-amino-17a- methyl amino] platinum (Π), cis-dichloro-[3-methoxy-20b-amino-2α-methyl-amino-pregna] platinum (Π) and cis-dichloro-5a-androstan-3-ylo-17b-ol-3b-amino-3a-methyl amino] platinum (II). The above complexes have a significant pharmacological efficacy, since their anti-cancer effect is similar to cisplatin as well as their additional ability to connect with the equivalent receptors (=RBA, Receptor Binding Affinity) is one of the best that has ever been reported for such a compound category.
机译:本发明涉及顺式-二氯-[3-羟基-D1.3.5(10)-雌三烯-17b-氨基-17a-甲基氨基]铂(Π),顺式-二氯-的化合物,分离和表征。 [3-甲氧基-20b-氨基-2α-甲基-氨基-pregna]铂(Π)和顺二氯5a-雄烷-3-ylo-17b-ol-3b-氨基-3a-甲基氨基]铂(II )。上述复合物具有显着的药理功效,因为它们的抗癌作用与顺铂相似,并且它们与等效受体(= RBA,受体结合亲和力)的连接能力是迄今为止报道过的最好的药物之一。这样的复合类别。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号